EUVIMEDEUVIMED entdecken
Crossref

Sustained and Step-Wise Drug Release by a Novel Double Responsive Dendrimer- N -Acetylcysteine Conjugate

Ozgul Gok, Anjali Sharma, Siva P Kambhampati, Elizabeth Smith Khoury, Sujatha Kannan, Rangaramanujam M Kannan iD

Biomacromolecules · 2025

DOI: 10.1021/acs.biomac.5c00283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, 2025. Verfasst von Ozgul Gok und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Nanomedicine, Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, U…. Hauptthemen laut MEDLINE: Dendrimers, Acetylcysteine, Anti-Inflammatory Agents. Die Arbeit nennt 63 Literaturangaben. Gefördert von: National Institute of Biomedical Imaging and Bioengineering.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polyamidoamine (PAMAM) dendrimers have emerged as promising vehicles for targeting the brain due to their intrinsic ability to penetrate through the injured blood-brain barrier. Herein, we present a novel drug delivery system based on a fourth generation PAMAM dendrimer as a brain targeting nanomedicine for the delivery of an anti-inflammatory drug N-acetyl cysteine with a sustained drug release profile. This D"ester"(NAC"ss"NAC) design enables NACs conjugated to the periphery of PAMAM dendrimers in the dimer form with ester and disulfide bonds to be sequentially released in a stepwise manner, responding to environmental pH and redox potential. Moreover, in vitro studies were conducted with a fluorescently labeled conjugate to confirm its nontoxic behavior and time-dependent cellular uptake, together with improved anti-inflammatory and antioxidative effects over endotoxin-activated microglia. These findings demonstrate that the DNACNAC conjugate has a high potential to be utilized as a promising dendrimer-based nanomedicine platform for prolonged treatment of neuroinflammation-related CNS disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DendrimersAcetylcysteineAnti-Inflammatory AgentsDrug LiberationAnimalsMicrogliaDelayed-Action PreparationsMiceBlood-Brain BarrierDrug Delivery SystemsHumansAntioxidants

Substanzen

DendrimersAcetylcysteinePAMAM StarburstDelayed-Action PreparationsAnti-Inflammatory AgentsAntioxidants

Autor:innen und Institutionen

  • Center for Nanomedicine, Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, United States.
  • Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, United States.
  • Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, Maryland 21287, United States.
  • Departments of Chemical and Biomolecular Engineering, and Materials Science and Engineering, Johns Hopkins University, Baltimore, Maryland 21287, United States.

ORCID-Profile: Rangaramanujam M Kannan

Förderung

  • National Institute of Biomedical Imaging and Bioengineering

Zitieren

APA

Gok, O., Sharma, A., Kambhampati, S. P., Smith Khoury, E., Kannan, S., & Kannan, R. M. (2025). Sustained and Step-Wise Drug Release by a Novel Double Responsive Dendrimer- N -Acetylcysteine Conjugate. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c00283

Vancouver

Gok O, Sharma A, Kambhampati SP, Smith Khoury E, Kannan S, Kannan RM. Sustained and Step-Wise Drug Release by a Novel Double Responsive Dendrimer- N -Acetylcysteine Conjugate. Biomacromolecules. 2025. doi:10.1021/acs.biomac.5c00283

BibTeX
@article{Gok2025,
  author = {Gok, Ozgul and Sharma, Anjali and Kambhampati, Siva P and Smith Khoury, Elizabeth and Kannan, Sujatha and Kannan, Rangaramanujam M},
  title = {Sustained and Step-Wise Drug Release by a Novel Double Responsive Dendrimer- N -Acetylcysteine Conjugate},
  journal = {Biomacromolecules},
  year = {2025},
  doi = {10.1021/acs.biomac.5c00283}
}
Kostenlos starten →